prikaz prve stranice dokumenta Extracorporeal blood purification strategies in sepsis and septic shock: An insight into recent advancements
  Preuzmi
PDF 1.33 MB
Znanstveni rad - Pregledni rad
Extracorporeal blood purification strategies in sepsis and septic shock: An insight into recent advancements
World Journal of Critical Care Medicine, 12 (2023), 2; 71-88. https://doi.org/10.5492/wjccm.v12.i2.71
Mehta, Yatin; Paul, Rajib; Ansari, Abdul Samad; Banerjee, Tanmay; Gunaydin, Serdar; Nassiri, Amir Ahmad; Pappalardo, Federico; Premužić, Vedran; Sathe, Prachee; Singh, Vinod; Vela, Emilio Rey

Citirajte ovaj rad

Mehta, Y., Paul, R., Ansari, A. S., Banerjee, T., Gunaydin, S., Nassiri, A. A. ... Vela, E. R. (2023). Extracorporeal blood purification strategies in sepsis and septic shock: An insight into recent advancements. World Journal of Critical Care Medicine, 12. (2), 71-88. doi: 10.5492/wjccm.v12.i2.71

Mehta, Yatin, et al. "Extracorporeal blood purification strategies in sepsis and septic shock: An insight into recent advancements." World Journal of Critical Care Medicine, vol. 12, br. 2, 2023, str. 71-88. https://doi.org/10.5492/wjccm.v12.i2.71

Mehta, Yatin, Rajib Paul, Abdul Samad Ansari, Tanmay Banerjee, Serdar Gunaydin, Amir Ahmad Nassiri, Federico Pappalardo, et al. "Extracorporeal blood purification strategies in sepsis and septic shock: An insight into recent advancements." World Journal of Critical Care Medicine 12, br. 2 (2023): 71-88. https://doi.org/10.5492/wjccm.v12.i2.71

Mehta, Y., et al. (2023) 'Extracorporeal blood purification strategies in sepsis and septic shock: An insight into recent advancements', World Journal of Critical Care Medicine, 12(2), str. 71-88. doi: 10.5492/wjccm.v12.i2.71

Mehta Y, Paul R, Ansari AS, Banerjee T, Gunaydin S, Nassiri AA, i sur.. Extracorporeal blood purification strategies in sepsis and septic shock: An insight into recent advancements. World Journal of Critical Care Medicine [Internet]. 2023. [pristupljeno 16.03.2025.];12(2):71-88. doi: 10.5492/wjccm.v12.i2.71

Y. Mehta, et al., "Extracorporeal blood purification strategies in sepsis and septic shock: An insight into recent advancements", World Journal of Critical Care Medicine, vol. 12, br. 2, str. 71-88, 2023. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:271509. [Citirano: 16.03.2025.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:271509
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Extracorporeal blood purification strategies in sepsis and septic shock: An insight into recent advancements
AutorYatin Mehta
AutorRajib Paul
AutorAbdul Samad Ansari
AutorTanmay Banerjee
AutorSerdar Gunaydin
AutorAmir Ahmad Nassiri
AutorFederico Pappalardo
AutorVedran Premužić
AutorPrachee Sathe
AutorVinod Singh
AutorEmilio Rey Vela
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
(KATEDRA ZA INTERNU MEDICINU)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Sažetak (engleski)
Background: Despite various therapies to treat sepsis, it is one of the leading causes of mortality in the intensive care unit patients globally. Knowledge about the pathophysiology of sepsis has sparked interest in extracorporeal therapies (ECT) which are intended to balance the dysregulation of the immune system by removing excessive levels of inflammatory mediators. Aim: To review recent data on the use of ECT in sepsis and to assess their effects on various inflammatory and clinical outcomes. Methods: In this review, an extensive English literature search was conducted from the last two decades to identify the use of ECT in sepsis. A total of 68 articles from peer-reviewed and indexed journals were selected excluding publications with only abstracts. Results: Results showed that ECT techniques such as high-volume hemofiltration, coupled plasma adsorption/filtration, resin or polymer adsorbers, and CytoSorb® are emerging as adjunct therapies to improve hemodynamic stability in sepsis. CytoSorb® has the most published data in regard to the use in the field of septic shock with reports on improved survival rates and lowered sequential organ failure assessment scores, lactate levels, total leucocyte count, platelet count, interleukin- IL-6, IL-10, and TNF levels. Conclusion: Clinical acceptance of ECT in sepsis and septic shock is currently still limited due to a lack of large random clinical trials. In addition to patient-tailored therapies, future research developments with therapies targeting the cellular level of the immune response are expected.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Pregledni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaWorld Journal of Critical Care Medicine
Brojčani podacivol. 12, br. 2, str. 71-88
p-ISSN2220-3141
DOIhttps://doi.org/10.5492/wjccm.v12.i2.71
URN:NBNurn:nbn:hr:105:271509
Datum objave publikacije2023
URL dokumentahttps://www.wjgnet.com/2220-3141/full/v12/i2/71.htm
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje-Nekomercijalno 4.0 međunarodna (CC BY-NC 4.0)
Datum i vrijeme pohrane2023-11-24 14:35:20